These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 18178859)
1. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346 [TBL] [Abstract][Full Text] [Related]
3. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469 [TBL] [Abstract][Full Text] [Related]
4. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer. Brown GR; Silva MD; Thompson PA; Beutler B Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218 [TBL] [Abstract][Full Text] [Related]
5. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
6. Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice. Mora C; Grewal IS; Wong FS; Flavell RA Int Immunol; 2004 Feb; 16(2):257-64. PubMed ID: 14734611 [TBL] [Abstract][Full Text] [Related]
7. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. Hussain S; Delovitch TL J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886 [TBL] [Abstract][Full Text] [Related]
8. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883 [TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924 [TBL] [Abstract][Full Text] [Related]
10. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153 [TBL] [Abstract][Full Text] [Related]
11. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content. Füchtenbusch M; Larger E; Thebault K; Boitard C Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920 [TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Christianson SW; Shultz LD; Leiter EH Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606 [TBL] [Abstract][Full Text] [Related]
13. Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene. Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343 [TBL] [Abstract][Full Text] [Related]
15. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes. Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869 [TBL] [Abstract][Full Text] [Related]
16. Significant role for Fas in the pathogenesis of autoimmune diabetes. Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090 [TBL] [Abstract][Full Text] [Related]
17. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Yang Y; Bao M; Yoon JW Diabetes; 2001 Dec; 50(12):2691-9. PubMed ID: 11723051 [TBL] [Abstract][Full Text] [Related]
18. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
20. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]